NIH-funded research Career grant

Creating a smartphone app to help young adults reduce nicotine vaping

Official title: Developing a smartphone-based intervention targeting high-risk situations of nicotine vaping among young adults

Funded at University of California, San Francisco · NIH-11036293 · Data updated 2026-11-12

This study is creating a helpful smartphone app for young adults aged 18-25 who want to cut down on e-cigarette use, offering personalized tips and support based on their vaping habits.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startFebruary 15, 2024
Project endJanuary 31, 2029
Funding year2025
Award (this year)$196,884
NIH project number5K01DA056693-02
Project IDNIH-11036293 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are young adults aged 18-25 who currently use e-cigarettes and are looking to reduce or quit their vaping habits.

Less likely to help

Patients who do not use e-cigarettes or are outside the age range of 18-25 may not benefit from this research.

What this research studies

This research aims to develop a smartphone-based intervention specifically designed to help young adults aged 18-25 reduce their use of e-cigarettes. The approach combines mobile health technology with clinical treatment strategies to address nicotine vaping in high-risk situations. The project will utilize machine learning to analyze data collected through the app, allowing for personalized support and interventions. Participants will engage with the app to track their vaping habits and receive tailored feedback and resources.

Why it matters

Potential benefit: If successful, this research could significantly reduce nicotine vaping among young adults, leading to improved health outcomes.

How similar studies have gone: Previous research has shown success in using mobile health interventions for smoking cessation, indicating a promising approach for this target population.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Nguyen, Nhung — University of California, San Francisco
  • Study coordinator: Nguyen, Nhung

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.